| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |